跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,882 条关于
“PFL-241/STX-241”
全部
8,882
临床试验
5,526
药物
2,432
机构
162
资讯
762
去年
Pierre Fabre and Scorpion Therapeutics Initiate Phase I/II Trial of EGFR Inhibitor PFL-241/STX-241 in NSCLC
去年
Pierre Fabre Acquires Global Rights to Next-Generation EGFR Inhibitors for NSCLC Treatment
去年
Eli Lilly Acquires Scorpion's Cancer Drug STX-478 in $2.5 Billion Deal
去年
Vicebio Secures $100 Million to Advance RSV and hMPV Combination Vaccine
4个月前
Scienture Secures Third Patent for ARBLI Losartan Oral Suspension, Extending Market Exclusivity Through 2041
去年
Novel Molecular Classification System for Retroperitoneal Liposarcoma Reveals Two Distinct Prognostic Subtypes
去年
Pierre Fabre's PFL-002/VERT-002 Enters Phase I/II Trial for NSCLC with MET Alterations
去年
Pierre Fabre's PFL-002/VERT-002 Enters Phase I/II Trial for NSCLC with MET Alterations
去年
Physical Activity in Childhood Linked to Better Mental Health and Cognitive Function in Adolescence
去年
Moderna Reports 41% Revenue Decline in Q2 2025, Launches $1.5 Billion Cost-Cutting Initiative
第 1 页,共 77 页
上一页
下一页